PR Newswire·Nov 10, 2026, 7:45 AM ET

Curaleaf Receives All Required Competition Law Clearances for Proposed Acquisition of Aurora Cannabis

Curaleaf Holdings, Inc. received competition law clearances in Germany and Canada for its proposed acquisition of Aurora Cannabis Inc.
Germany's Federal Ministry for Economic Affairs and Energy approved the acquisition of 100% of Aurora's German entities on October 20, 2026.
Canada's Competition Bureau issued a no-action letter on November 2, 2026, confirming it would not challenge the acquisition under the Competition Act.
Germany's Federal Cartel Office confirmed on November 3, 2026, that the transaction does not meet conditions for prohibition.
Curaleaf's enhanced premium bid remains outstanding with an expiration date of December 4, 2026.
Curaleaf states that securing these clearances strengthens its offer by providing greater certainty of completion compared to Organigram's competing proposal.
The document clarifies that the offer is made solely through the Offer to Purchase and Circular dated August 18, 2026, amended October 6, 2026.
Curaleaf has filed required Registration Statements on Form F-80 and Tender Offer Statements on Schedule 14D-1F with the U.S. SEC.
The Curaleaf subordinate voting shares have not been approved by the SEC or any U.S. state securities commission.
Forward-looking statements regarding the offer are included but are subject to risks that could cause actual results to differ materially.